Tag: New Mexico

Pandora Report 3.7.2025

by dkellogg97, posted in Pandora Report

This week’s Pandora Report covers updates on the Trump administration’s response to the West Texas measles outbreak, challenges at NIH, possible budget cuts to DOD programs focused on WMDs and pandemic preparedness, and more.

Biodefense MS Information Session

“Prospective students are invited to attend a information session to hear more about the Biodefense M.S. program offered at the Schar School. The online session will provide an overview of the program, as well as the application process, student experience and graduate outcomes. This session admissions will be led by the Graduate Admissions team.”

This sessions will take place at 12 pm EDT on March 20. Learn more and register here.

Updates on the Trump Administration

Top HHS Officials Retire and Resign

Francis S. Collins, the well-known geneticist who ran the National Institutes of Health for 12 years, announced on Saturday that he has retired from the NIH and the federal government. Collins did not provide a reason for his departure, and he has refused to do any interviews. His parting statement offered a subtle yet pointed message to the Trump administration, with Collins writing in part “As I depart N.I.H., I want to express my gratitude and love for the men and women with whom I have worked side by side for so many years. They are individuals of extraordinary intellect and integrity, selfless and hard-working, generous and compassionate. They personify excellence in every way, and they deserve the utmost respect and support of all Americans.”

Tom Corry, Assistant Secretary of Public Affairs at HHS, also abruptly resigned from the department last Friday, just two weeks after starting his new role. Corry did not provide a reason for his departure either. He previously served as a senior advisor and Director of Communications at the Centers for Medicare & Medicaid Services during the first Trump administration.

Kennedy Embraces Unconventional Remedies as Measles Outbreak Grows

As the West Texas measles outbreak grows, HHS Secretary RFK Jr. has touted several unconventional remedies while continuing to not urge all Americans to get vaccinated against the disease. In an interview, Kennedy said the federal government is shipping doses of vitamin A to Gaines County, Texas, the epicenter of the outbreak, and helping to arrange ambulance rides. He also claimed that physicians in Texas have seen “very, very good results” treating measles with budesonide, clarithromycin, and cod liver oil. This has prompted strong backlash from many in the medical community.

As of March 6, 222 cases have been reported in Alaska, California, Florida, Georgia, Kentucky, New Jersey, New Mexico, New York City, Pennsylvania, Rhode Island, Texas, and Washington. The US eliminated measles in 2000. Today, an unvaccinated adult in New Mexico has been reported dead, a little over a week after the death of an unvaccinated child in Lubbock, Texas. The Pan American Health Organization issued an epidemiological alert in response to the outbreak earlier this week.

Bhattacharya Promises “Scientific Dissent” at NIH

Jay Bhattacharya, Donald Trump’s nominee for NIH director, said on Wednesday that NIH officials “oversaw a culture of coverup, obfuscation, and a lack of tolerance for ideas that differed from theirs” in recent years. He promised to, in response to this, “establish a culture of respect for free speech in science and and scientific dissent at the agency.”

Bhattacharya infamously co-authored the Great Barrington Declaration in October 2020, which argued for allowing people at lower risk of COVID-19 complications to go about life as normal, assuming that, if infected, they would experience mild disease and contribute to herd immunity. NPR explains that, “During the COVID pandemic, Bhattacharya clashed with the mainstream medical establishment, including the NIH, over lockdowns and other measures designed to control the spread of the virus. He says he was shunned and penalized for his views and he didn’t want anyone else to suffer the same fate.”

NIH Set to Terminate Active Research Grants

The NIH has begun mass terminations of research grants funding active scientific projects that no longer meet “agency priorities”. According to Nature News, “NIH staff members have been instructed to identify and potentially cancel grants for projects studying transgender populations, gender identity, diversity, equity and inclusion (DEI) in the scientific workforce, environmental justice and any other research that might be perceived to discriminate on the basis of race or ethnicity, according to documents and an audio recording that Nature has obtained. Grants that allot funding to universities in China and those related to climate change are also under scrutiny.”

This comes after a federal court temporarily blocked the administration’s proposed cut to NIH funding for universities’ indirect costs like facilities and administration. However, as Politico points out, the administration may pivot to renegotiating the payments with individual universities.

DOD Cuts Threaten Pandemic Preparedness, WMD Proliferation Prevention, and More

DOD agencies responsible for preventing WMD proliferation and building security capacity globally are at risk of intense budget cuts or outright abolition. According to a recent draft working paper, DOD is asking all agencies and services that oversee security cooperation programs to assess potential impacts of funding realignment. The paper was prepared in response to an RFI from Secretary of Defense Pete Hegseth that asked agencies to assess consequences of four levels of staff reduction, including 25%, 50%, 75%, and 100%. The authors of the working paper, according to WIRED, “…warn that the cuts could hobble the fight against organized crime in South America, impair the battle against the Islamic State, increase the likelihood of a rogue state producing and using chemical weapons, and defund pandemic surveillance measures.”

CDC Staff Now Prohibited from Co-Authoring Papers with WHO Personnel

Scientists at the CDC are now prohibited from co-authoring publications with WHO staff, according to reporting from HuffPost. An interim guidance document obtained by the news agency explained that “CDC staff should not be co-authors on manuscripts/abstracts with WHO staff,” while also adding that CDC staff should not author publications related to work that is “funded by WHO.” The guidance further instructs CDC staff who are lead authors on such publications to either pause all action on those publications, or to recuse themselves as authors if the publication process cannot be paused. It also says that manuscripts not in compliance with Trump’s executive orders that were submitted prior to January 20 should be withdrawn, or CDC staff should recuse themselves as authors.

US Funding Cuts Threaten Global Fight Against TB

The WHO issued a warning on Wednesday explaining that severe funding cuts (namely, those in the United States) threaten decades of progress in the global fight against tuberculosis. The agency explained that essential prevention, testing, and treatment services are collapsing, leaving millions at risk. The regions most affected include Africa, Southeast Asia, and the Western Pacific, where national TB programs depend on international support.

The TB Community Coordination Hub said in a statement about the funding cuts, “[We] strongly condemn this callous, abrupt and totally one-sided act that is unprecedented, and calls upon the US Administration to take immediate measures to restore funding and support projects globally that are crucial to contain and prevent a resurgence of this deadly disease.”

Further Reading:

CDC Monitoring Mysterious Disease in DRC

In a statement on Tuesday, the CDC said it is closely monitoring the outbreak of an unknown disease that has already killed dozens in the Democratic Republic of Congo. According to WHO, at least 1,318 people have exhibited symptoms of the disease, and 60 had died from it by February 27. A new mpox variant was also recently discovered in the country. The new variant has a mutation known as APOBEC3, which indicates it may be more easily transmissible than previously identified strains.

“WHO Technical Advisory Group on the Responsible Use of the Life Sciences and Dual-Use Research: Report of the Meeting, 30 October 2024”

From WHO: “The World Health Organization (WHO) Technical Advisory Group on the Responsible Use of the Life Sciences and Dual-Use Research (TAG-RULS DUR) was established to provide independent advice to WHO on the monitoring and mitigation of biorisks, the advances in the life sciences and related technologies, the governance of dual-use research and the responsible use of the life sciences. This report summarizes the meeting that was virtually held on 30 October 2024. Over the course of the meeting, participants discussed and provided feedback on activities to operationalize the framework and delivered updates on activities of the TAG-RULS DUR’s four working groups.”

“A WHO Global Framework to Guide Investigations Into Origins of Potentially Epidemic and Pandemic Pathogens”

The Scientific Advisory Committee for the Origins of Novel Pathogens (SAGO) and WHO SAGO Secretariat recently published this comment in Nature, writing in its introduction “In outbreak situations involving a novel pathogen timely and coordinated response is crucial. The WHO Scientific Advisory Group for the Origins of Novel Pathogens recently released a global framework to guide future scientific investigations into the origin of emerging pathogens.”

“Recent Virus Research Should Raise the Alarm”

W. Ian Lipkin and Ralph Baric recently published this opinion piece in The New York Times: “There’s a central question that many scientists face: How can scientific discoveries drive humanity’s progress without posing a dire risk to it? As virus experts, we’re committed to research that uncovers pandemic threats and helps protect people from them. But we are concerned about how some scientists are experimenting with viruses in ways that could put all of us in harm’s way.”

“From Inception to Fielding: Meeting the Challenges of Medical Countermeasure Development”

Sarah M. Wiles recently published this article in CBNW: “The U.S. Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense has a robust development process for new CBRN medical countermeasures. Sarah M. Wiles explains the process and its rationale.”

“Automated Grading for Efficiently Evaluating the Dual-Use Biological Capabilities of Large Language Models”

Bria Persaud, Ying-Chiang Jeffrey Lee, Jordan Despanie, Helin Hernandez, Henry Alexander Bradley, Sarah L. Gebauer, Greg McKelvey, Jr. recently published this RAND Corporation working paper: “The authors of this working paper developed a proof-of-concept automated grader and used it to assess large language models’ abilities to answer knowledge-based questions and generate protocols that explain how to perform common laboratory techniques that could be used in the creation of proxies for biological threats.”

“UNIDIR Empowers Emerging Leaders in Biological Disarmament and Biosecurity”

From UNIDIR: “As the world marks the 50th anniversary of the Biological Weapons Convention (BWC), UNIDIR alongside the DiploFoundation and the Fondation pour la Recherche Stratégique celebrates the successful completion of the inaugural BWC Advanced Education Course (BWCedu). This five-month advanced training programme – funded by the UK’s Foreign, Commonwealth & Development Office – brought together 25 emerging leaders from a diverse range of States, with a focus on participants from the Global South.”

Read here.

“Seven Years Since Salisbury Was Centre of Novichok Attack”

Isabella Holliday recently authored this news article about the anniversary of the Novichok attack targeting the Skripals in Salisbury, UK. Read it in the Salisbury Journal here.

“Syria’s Caretaker Foreign Minister Addresses OPCW’s Executive Council”

From OPCW: “In a landmark visit to OPCW’s Headquarters in The Hague, caretaker Foreign Minister al-Shaibani reaffirmed the commitment of the new Syrian authorities to cooperate with the OPCW to eliminate the chemical weapons programme of the former Syrian regime”.

Read here.

ICYMI: The Cost of Defunding PEPFAR and the Impact on the Fight Against HIV/AIDS

Brown’s Pandemic Center hosted this webinar in late February. Watch the recording here. Key topics included:

“Call for Action – How policymakers, philanthropists, and institutions can mobilize to address these urgent gaps.”

“PEPFAR Changes & Uncertainty – Concerns about funding gaps, particularly affecting pediatric HIV treatment, maternal health, and job losses in healthcare.”

“Impact on South Africa & Beyond – The success of PEPFAR in South Africa and the potential consequences of its reduction, including rising HIV cases and strain on health systems.”

“Future of Global Health Funding – Exploring alternative funding sources, the role of UNICEF, private sector involvement, and the need for governments to step up.”

NEW: Building Trust in the H5N1 Response: Perspectives from the Field

From NASEM: “Since avian influenza (H5N1) was first detected in dairy cattle in March 2024, H5N1 has resulted in human infections, diminished livestock production, and decimated wildlife populations. Uncoordinated policies at the national, state, and local levels have challenged mitigation efforts, and mistrust has hindered the urgent response needed for the rapidly evolving threat. The National Academies Forum on Microbial Threats will host a public webinar on March 27 where agricultural producers and workforce health specialists will explore strategies to build greater mutual trust and a coordinated One Health response.”

This webinar will take place on March 27 at 2 pm ET. Register here.

2025 Scowcroft Institute Pandemic Policy Summit

From the Scowcroft Institute: “The Scowcroft Institute of International Affairs at Texas A&M University invites you to attend the 2025 Scowcroft Institute Pandemic Policy Summit examining the ongoing H5N1 outbreak across the U.S. Dairy industry. This summit will bring together experts from government, academia, and industry to review the response efforts, discuss current challenges and opportunities, and identify options for moving forward. Listen to panels of subject matter experts, explore case studies from the field, and participate in networking opportunities.”

This event will take place on March 18 in Washington, DC. Learn more and RSVP here.

Sustainable Manufacturing: Building and Preserving a Resilient Medical Industrial Base

“Join industry and government partners for our second annual industry summit! During this event, leaders from IBMSC will share our strategic vision and organizational priorities. Speakers will also share potential opportunities for building and preserving the medical industrial base.  This event will be in-person only and space is limited!”

This event will take place March 11-12 in Washington, DC. Learn more and register here.

Gaming Weapons of Mass Destruction Course – From Policy to Practice

From MORS: “Gaming Weapons of Mass Destruction (WMD – defined as Nuclear, Chemical, and Biological agents) will be a three-day course focused on developing and executing games related to WMD in all its forms. While the basics of WMD capabilities and game design will be discussed, this will be a course focused on the intersection of WMD and gaming. It will not be either a WMD or gaming course; for those topics see other offerings.”

“No prior experience is required for this course, though a basic familiarity with various agents and their effects would be helpful, as would a basic understanding of professional gaming and how it is used.  The instructors will adapt in real time to class requirements (e.g., if the class is interested in animal and plant targets, the instructors have extensive experience in designing games on those subjects as well).”

This course will take place March 18-20 on Zoom. Learn more and register here.

NEW: Apply for the 2025 Youth for Biosecurity Fellowship

“The global norm against biological weapons cannot be maintained without the inclusion of youth voices in the multilateral discussions taking place in the framework of the Biological Weapons Convention (BWC). Youth perspectives are key to create innovative solutions and generate long-term engagement. There are benefits to including the perspectives of young people from developing countries, where over 90% of the world’s youth reside.”

“Organized by the United Nations Office for Disarmament Affairs in Geneva, in partnership with key international actors that empower youth in science diplomacy and global biosecurity, the Youth for Biosecurity Fellowship provides a unique learning and networking experience in the framework of the Biological Weapons Convention.”

“Launched in 2019 as a Biosecurity Diplomacy Workshop, the Youth for Biosecurity Initiative organized its first fellowship in 2023. For the third edition, the fellowship will provide the opportunity for 20 competitively selected young scientists from the Global South to join an online interactive training programme prior to a field visit during the meeting of the BWC Working Group on the Strengthening of the Convention in Geneva.”

Learn more and apply by April 7 here.

NASEM Has Questions 

The National Academy of Science, Engineering, and Medicine (NASEM) is hosting a workshop on Navigating the Benefits and Risks of Publishing Studies of In Silico Modeling and Computational Approaches of Biological Agents and Organisms on April 3-4 in Washington, DC. In preparation for the workshop, NASEM is soliciting input on how publishing computational models can support biological research while minimizing potential DURC/PEPP risks. The purpose of the questionnaire is to ascertain if organizations that publish or disseminate scientific knowledge have considered or created guidelines or policies to review, host or interact with in silico and computational models and tools, studies, datasets, etc. research that constitutes dual use, dual use research of concern (DURC) or pathogens with enhanced pandemic potential (PEPP). Have answers? Then fill out the In Silico Research Publications Pre-event Questionnaire. 

NOFO, Addressing Agricultural Biorisk Evidence Base Gaps with Applied Research
“There is a global recognition that the current evidence base to inform laboratory biological risk management has gaps, and that biosafety and biosecurity policies are not always based on evidence.1 This notice of funding will support the design and implementation of applied biorisk research to address evidence gaps in working with high-consequence veterinary and agricultural pathogens as identified during the RAV3N Biorisk and Biosafety Gap Assessment Workshop2 or similar gap analysis like the WOAH working group agent specific biorisk gap analysis.1  ERGP is seeking proposals that address one or more key focus area components listed below. Each proposal will go through an internal ERGP and external expert review. Successful proposals should address at least one of the three key focus areas and at least one component under that area.”

“This funding opportunity aims at the design and implementation of applied biorisk research to address evidence gaps in working with high-consequence veterinary and agricultural pathogens.”

“This work will contribute to recommended guidance on laboratory biosafety and agricultural biosecurity, using research techniques to evaluate the application and effectiveness in operational contexts. All proposals must make a clear experimental plan for how the applicant will test the application and outcomes of their focus area(s)/component(s) in their facility.”

Learn more and submit application by April 14 here.

Pandora Report 3.29.2024

by dkellogg97, posted in Pandora Report

This week’s Pandora Report covers the creation of the National Bioeconomy Board, reports of HPAI infections in cattle in multiple states, a new PBS public health docu series, new professional opportunities, and more.

Biodefense PhD Student Presents Research at 2024 Preparedness Summit

Kimberly Ma, a PhD student in the Biodefense Graduate Program, recently presented her research at the 2024 Preparedness Summit in Cleveland. She told the Pandora Report a bit about it, saying “This week, I had the fortune to once again attend the Preparedness Summit in Cleveland. This was my third time attending, but this time, instead of as a public health worker, I came in my personal and Ph.D. student capacity to present my poster “Bioterrorism Risk Communications: Where Are We Now?” and a session born out of a peer-reviewed article in Health Security that I wrote with preparedness leaders across the country, “Reimagining Incident Management Systems for Public Health Responses.”

Read more about her experience here.

White House Launches National Bioeconomy Board

The White House recently announced that it is launching the National Bioeconomy Board to help manage the economic impact of biotechnology and biomanufacturing. In a blog post for the Office of Science and Technology Policy (OSTP), Sarah Glaven, OSTP’s Principal Assistant Director for Biotechnology and Biomanufacturing, Industrial Innovation, explained “Biotechnology harnesses the power of biology to create new services and products, which provide opportunities to grow the U.S. economy and workforce and improve the quality of our lives and the environment. This week, the Biden-Harris Administration took an important step toward realizing the potential of biotechnology for the U.S. economy by launching the National Bioeconomy Board. The Board will work with partners across the public and private sectors to advance societal well-being, national security, sustainability, economic productivity, and competitiveness through biotechnology and biomanufacturing.”

The same blog explains that “The National Bioeconomy Board is co-chaired by the White House Office of Science and Technology Policy (OSTP), the Department of Commerce (DOC), and the Department of Defense. The Board also includes representatives from nine additional federal departments and agencies: The State Department, National Science Foundation, Department of Homeland Security, Department of Health and Human Services, National Aeronautics and Space Administration (NASA), Department of Justice, Department of Energy, Department of Agriculture (USDA) and the Office of the Director of National Intelligence. Board members represent the variety of biotechnology and biomanufacturing stakeholders across the federal government, including departments and agencies that promote economic development, sponsor fundamental research, facilitate technology commercialization, focus on safety and security, and engage in workforce training.”

The creation of the Board accompanies the Inflation Reduction Act, Bipartisan Infrastructure Law, and CHIPS and Science Act as part of the administration’s Investing in America agenda, which aims “…to revitalize U.S. manufacturing, bolster national security, and build a sustainable economy for all Americans. The strategy is catalyzing investment in the bioeconomy: since the start of the Biden-Harris Administration, private companies have announced over $20 billion in biomanufacturing investments.”

Bird Flu Detected in Texas, Kansas, and New Mexico

On March 25, USDA officials reported cows in Texas, Kansas, and New Mexico were sick with what is presumed to be the H5N1 influenza virus that has already killed millions of birds. These cattle infections are spoiling milk and causing disease in older animals, with some impacted farms also reporting that dead birds have been discovered on their property, potentially explaining the source of the cattle infections. A case of highly pathogenic avian influenza was detected in a Minnesotan goat earlier this month, marking the first US livestock case of a disease that very rarely spreads between mammalian species.

An article for Science News explains that “Gregory Gray, an epidemiologist at the University of Texas Medical Branch, calls the new detections in cows across multiple states a “worrisome” development because it may signal this bird flu strain is spreading directly between cattle, instead of via birds, and has mutated in ways that could allow it to better infect people. But preliminary studies on the affected cows show no signs that the virus has changed, the National Veterinary Services Laboratories said in a statement yesterday.”

The threat to the public is still considered low, though human cases have been reported recently in Cambodia and Vietnam.

“National Road Map to Invest in RNA Science and Biotechnology”

This write-up from Global Biodefense breaks down a recent report from the National Academies that “charts a course for developing technologies and infrastructure that would enable the determination of any epitranscriptome of scientific and public interest.” The write-up explains in part “Currently, without knowing the exact composition of all RNA molecules that derive from each gene, researchers’ ability to understand the molecular underpinnings of health and disease is severely limited. Every cell in every organism has a different set of modified RNA molecules that make up its epitranscriptome. Epitranscriptomes are constantly changing as cells develop and respond to their environment. RNA can act as an indicator about a patient’s health, is a potential pathway for delivering treatments, and provides real-time information about what is changing and happening in an organism.”

“Charting a Future for Sequencing RNA and Its Modifications: A New Era for Biology and Medicine”

From the National Academies: “Concerted efforts to deepen understanding of RNA modifications and their role in living systems hold the potential to advance human health, improve crop yields, and address other pressing societal challenges. RNA, which carries the information encoded by DNA to the places where it is needed, is amazingly diverse and dynamic. RNA is processed and modified through natural biological pathways, giving rise to hundreds, in some cases thousands, of distinct RNA molecules for each gene, thereby diversifying genetic information. RNA modifications are known to be pivotal players in nearly all biological processes, and their dysregulation has been implicated in a wide range of human diseases and disorders. Yet, our knowledge of RNA modifications remains incomplete, hindered by current technological limitations. Existing methods cannot discover all RNA modifications, let alone comprehensively sequence them on every RNA molecule. Nonetheless, what is known about RNA modifications has already been leveraged in the development of vaccines that helped saved millions of lives worldwide during the COVID-19 pandemic. RNA modifications also have applications beyond health, for example, enhancing agricultural productivity.”

“Charting a Future for Sequencing RNA and Its Modifications: A New Era for Biology and Medicine calls for a focused, large-scale effort to accelerate technological innovation to harness the full potential of RNA modifications to address pressing societal challenges in health, agriculture, and beyond. This report assesses the scientific and technological breakthroughs, workforce, and infrastructure needs to sequence RNA and its modifications, and ultimately understand the roles RNA modifications play in biological processes and disease. It proposes a roadmap of innovation that will make it possible for any RNA from any biological system to be sequenced end-to-end with all of its modifications – a capability that could lead to more personalized and targeted treatments and instigate transformative changes across various sectors beyond health and medicine.”

“Future State of Smallpox Medical Countermeasures”

From the National Academies: “At the request of the Administration for Strategic Preparedness and Response, the National Academies convened a committee to examine lessons learned from the COVID-19 pandemic and mpox multi-country outbreak to inform an evaluation of the state of smallpox research, development, and stockpiling of medical countermeasures (MCM). In the resulting report, the committee presents findings and conclusions that may inform U.S. Government investment decisions in smallpox MCM readiness, as well as the official U.S. position on the disposition of live viral collections at future World Health Assembly meetings.”

Bonus: Read Mary Van Beusekom’s discussion of this report for CIDRAP

“Ten Years of High-Consequence Pathogens—Research Gains, Readiness Gaps, and Future Goals”

McQuiston, Montgomery, and Hutson recently published this commentary article in Emerging Infectious Diseases, explaining in part: “Despite successful variola virus eradication, orthopoxviruses remain high-consequence pathogens that create complex control challenges. During 2014–2024, reports of mpox caused by MPXV surged in regions where the virus is enzootic. During 2017–2022, increased reports of mpox in Nigeria initially raised little concern, even though mpox was diagnosed in occasional travelers from Nigeria who had no history of animal contact (9). In May 2022, MPXV clade II began circulating person-to-person globally, primarily through sexual contact among gay, bisexual, and other men who have sex with men (10). Thanks to smallpox preparedness work performed by the US Centers for Disease Control and Prevention and other partners, regulatory agency-approved diagnostics, the JYNNEOS vaccine (https://www.jynneos.comExternal Link), and TPOXX therapeutic agent (SIGA Technologies, https://www.siga.comExternal Link) were available in some countries; however, limited early supplies of the JYNNEOS vaccine and lack of licensure in some countries meant the vaccine was not accessible to all persons at risk for MPXV exposure. Before the global mpox outbreak, no real-world efficacy data for TPOXX was available; clinical trials are ongoing. After the mpox outbreak peak in 2022, MPXV has continued to circulate at low levels through 2024; since 2022, >90,000 cases have been reported worldwide (11). Since 2023, similar surveillance signals have been seen in DRC with MPXV clade I (12), raising concerns for another global mpox outbreak caused by a more lethal virus clade.”

“The Impact of Vaccines and Behavior on US Cumulative Deaths from COVID-19”

This Brookings summary of a paper authored by Andrew Atkeson and Stephen Kissler offers insight into potential approaches to addressing shortfalls in how the federal government manages massive amounts of public health data and the importance of both vaccines and behavioral changes in reducing overall COVID-19 deaths. The summary explains in part, “However, the authors write in “The Impact of Vaccines and Behavior on U.S. Cumulative Deaths from COVID-19,” the ad hoc effort’s effectiveness came as a surprise. Public health officials could not precisely target mitigation because they lacked precise information on the routes and mechanisms of the disease’s transmission.”

“Awaiting a Decision On New Research Regulations, Scientists Pen Dueling Articles to Shape ‘Gain-of-Function’ Policies”

Matt Field breaks down the scientific community’s responses to recommendations made by the National Science Advisory Board for Biosecurity last year in this article for The Bulletin of the Atomic Scientists, writing in part “As they await a decision on policies for potential pandemic pathogen research, dueling camps of scientists have emerged, weighing in through a journal article, responses to the article, and even responses to the responses. Those camps are seeking to undercut or boost the advisory recommendations developed in the wake of the COVID pandemic—and to bolster or diminish the suspicion that a lab accident could have caused it.”

“Ecological Countermeasures to Prevent Pathogen Spillover and Subsequent Pandemics”

Plowright et al. recently published this article in Nature: “Substantial global attention is focused on how to reduce the risk of future pandemics. Reducing this risk requires investment in prevention, preparedness, and response. Although preparedness and response have received significant focus, prevention, especially the prevention of zoonotic spillover, remains largely absent from global conversations. This oversight is due in part to the lack of a clear definition of prevention and lack of guidance on how to achieve it. To address this gap, we elucidate the mechanisms linking environmental change and zoonotic spillover using spillover of viruses from bats as a case study. We identify ecological interventions that can disrupt these spillover mechanisms and propose policy frameworks for their implementation. Recognizing that pandemics originate in ecological systems, we advocate for integrating ecological approaches alongside biomedical approaches in a comprehensive and balanced pandemic prevention strategy.”

“To Prevent Global Catastrophe, Governments Must First Admit There’s a Problem”

Rumtin Sepasspour and Courtney Tee recently published this piece in The Bulletin of the Atomic Scientists discussing political inaction on perceived risks of global catastrophe, writing in part “To properly prevent and prepare for the risk, governments must admit there’s a problem. Such an admission can only come with proper effort to assess and monitor global catastrophic risk, develop potential future scenarios, build and analyze intelligence, and invest in scientific and technical expertise.”

“Bibliometric Analysis of China’s Non-Therapeutic Brain-Computer Interface Research: Alternate Paths to Cognitive Augmentation and Control”

From CSET: “China’s brain-computer interface research has two dimensions. Besides its usual applications in neuropathology, China is extending the benefits of BCI to the general population, aiming at enhanced cognition and a “merger” of natural and artificial intelligence. This report, authored in collaboration with researchers from the Department of War Studies at King’s College London uses bibliometric analysis and expert assessment of technical documents to evaluate China’s BCI, and conclude that the research is on track to achieve its targets.”

“Russia’s Increasing Illegal Chemical Weapons Usage in Ukraine”

Tim Mak, Alessandra Hay, and Oksana Ostapchuk cover an interview with a survivor of a 2013 sarin gas attack in Syria and how inaction afterward has emboldened leaders like Vladimir Putin to use these weapons more frequently in this piece for The Counteroffensive. Warning: this article does contain graphic content.

“VX Nerve Agent Incident: Lessons Learned, Best Practices, and the Challenges Ahead”

From CBNW Magazine: “The 2017 VX nerve agent incident in Malaysia stands as a poignant demonstration of the catastrophic capability of asymmetrical chemical weapon threats, underscoring the critical necessity for increased attentiveness in averting and addressing such risks, writes Dr. Raja Subramanian.”

“CHEMEX Africa 2023: Interview with H.E. Ambassador Salima Abdelhak, P.R. of Algeria to OPCW”

From CBNW Magazine: “Taking place from September 23 to October 5, 2023, in the Algerian capital of Algiers, CHEMEX Africa was the first ever large-scale chemical emergency response exercise for African countries organized by the OPCW. CBNW Magazine Editor Patrick Norén spoke to the Permanent Representative (P.R.) of Algeria to the OPCW, H.E. Ambassador Salima Abdelhak, about the exercise and Algeria’s commitment to implementing the Chemical Weapons Convention (CWC). A full article on CHEMEX Africa containing extracts from this interview will be published in April.”

Read here.

What We’re Watching 🍿

The Invisible Shield

A new four-part docu series from PBS, “The Invisible Shield examines how public health makes modern life possible, but it is underfunded, undervalued and misunderstood putting our health at risk.”

Strem this series here.

NEW: The Future of U.S. Bulk Data Sharing and Use

From BIO-ISAC: “On February 28, 2024, the White House issued an Executive Order on Preventing Access to Americans’ Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern.”

“The Executive Order (EO) seeks to secure sensitive data from being shared with individuals, companies, and investors outside the US, particularly those connected to countries that may harm the US or its people.”

“The Department of Justice (DOJ) also issued a fact sheet and advanced notice of proposed rulemaking (ANPRM) regarding the proposed guidance and implementation strategies in the text.

  • What does this mean for the bioeconomy?
  • How has industry responded to this call for action?
  • What does this mean for the future of data sharing collaborations and research?”

“This collaborative discussion, with the BIO-ISAC community and representatives from the U.S. Department of Justice, will share an overview of the EO and ANPRM, explore the intent and efforts connected to these actions, and offer a Q&A session to review specific examples, pinch points, and ideas.”

This discussion will take place on April 5 at 12 pm EST. Learn more and register here.

NEW: EBRC & NIST Sequence Screening Virtual Workshop #1

From ERBC: “Synthetic DNA enables life sciences research that can be applied to pressing societal challenges across many sectors, but could also be used in the development of biological parts, systems, or organisms that cause great harm to human, public, or environmental health. Many companies that produce and sell synthetic DNA screen ordered sequences to prevent customers from inappropriately accessing Sequences of Concern (SOCs). This project aims to improve DNA synthesis screening by enabling the development of better tools and mechanisms for screening performance evaluation.”

“This will be the first workshop in the series. Additional virtual workshops will be held over the next six months, with an in-person meeting to be held in the fall. More details to come.”

This event will take place on April 9 at 1 pm EST. Learn more and register here.

NEW: The Advancing Threat Agnostic Biodefense Webinar Series

From PNNL: “Join us as we welcome Patrick Chain, scientist at Los Alamos National Laboratory (LANL). His talk, titled “Toward Pathogen-Agnostic Detection: Advances and Challenges in Shotgun Sequencing-Based Biosurveillance” will be Tuesday, April 16, at noon PT.”

“Patrick Chain leads the Metagenomics Applications, Bioinformatics, and Analytics Teams in the Bioscience Division at LANL, while also co-managing the Division’s Genomics Program. His team pioneers innovative algorithms and methods in bioinformatics and metagenomics, applying them to various research areas such as organism detection, sample characterization, and fundamental research across different ‘biomes’. With a background including a B.Sc. and M.Sc. from McMaster University and a Ph.D. from Michigan State University, Chain brings a wealth of expertise to the field.”

“The Advancing Threat Agnostic Biodefense Webinar Series brings together like-minded science and policy members of the biodefense community to discuss relevant research activities as well as barriers and enablers of a threat agnostic approach. The webinar series is hosted by the Nuclear, Chemical, and Biological Technology Division.”

Register here.

Artificial Intelligence and Automated Laboratories for Biotechnology: Leveraging Opportunities and Mitigating Risks

From the National Academies’ Board on Life Sciences: “Please join us April 3-4, 2024 for a hybrid workshop on the opportunities and mitigation of risks of the use of artificial intelligence and automated laboratories (i.e., self-driving labs) for biotechnology.”

“The workshop will consider opportunities to leverage AI and laboratory automation capabilities for discovery and development, explore methods and approaches to identify, track, and forecast the domestic and international development of such technologies, and convene experts across sectors to highlight recent advances and explore implications for the development and use of these technologies.”

Learn more and register here.

Launch of the 2024 National Blueprint on Biodefense

From the Bipartisan Commission on Biodefense: “On the 10th anniversary of its inception, the Bipartisan Commission on Biodefense will release its 2024 National Blueprint on Biodefense: Immediate Action Needed to Defend Against Biological Threats.”

“Please join us for this momentous event at the Congressional Auditorium, Capitol Visitor Center, on April 17th at 4:30pm.”

“The Bipartisan Commission on Biodefense (formerly the Blue Ribbon Study Panel on Biodefense) was established in 2014 to provide a comprehensive assessment of the state of United States biodefense efforts and to issue recommendations that foster change.  Subsequently, the Commission has briefed White House Administrations (including then Vice President Biden); testified before Congress; convened numerous meetings with experts; released 12 reports; produced the graphic novel Germ Warfare; and mobilized biodefense conversations and actions in the private and public sectors.”

Learn more and register here.

Addressing the Challenges Posed by Chemical and Biological Weapons: Intensive Online Introductory Course for Students of Technical Disciplines

“SIPRI and the European Union Non-Proliferation and Disarmament Consortium (EUNPDC) invite graduate and postgraduate students of the technical or natural science disciplines to apply for an intensive online introductory course on chemical and biological weapons—their proliferation, the efforts to eliminate them, the various mechanisms used to control their spread—and endeavours underway to reduce the risk of chemical or biological agents in terrorist attacks. The course will take place online, during four half-days on 28–31 May 2024, 14:00 to 18:00 Central European Summer Time (CEST).”

“The course will cover the fundamentals of chemical and biological weapons as well as of missiles and other means of delivery; the history of chemical and biological warfare; the evolution of international norms against these weapons; the threats associated with potential terrorist uses of chemical and biological material; bioweapons and other related scientific advances; the current challenges posed by chemical weapons; arms control treaties; and mechanisms to curb the spread of dangerous substances, including export controls.”

“The course will also discuss the role of the EU institutions and industry to address the challenges mentioned above. The course will be instructed by renowned experts on non-proliferation, arms control, disarmament, export controls, verification and related subjects from SIPRI, other European research centres, think tanks and international organizations.”

Learn more and apply here.

Registration for GHS 2024 Now Open

Registration is now open for the Global Health Security 2024 conference in Sydney, Australia. This iteration will take place 18-21 June, 2024. The call for abstracts is also still open. “The mission of the Global Health Security conference is to provide a forum where leaders, researchers, policy-makers, and representatives from government, international organisations, civil society, and private industry from around the world can engage with each other, review the latest research and policy innovations, and agree solutions for making the world safer and healthier. To that end, our mission is to help foster a genuinely multidisciplinary community of practice that is committed to working collaboratively to enhance global health security and eliminate disease, irrespective of its origin or source.”

SBA.3 International Synthetic Biology, and Biosecurity Conference in Africa

“Join us for the SBA.3 International Synthetic Biology and Biosecurity Conference in Africa, a groundbreaking event that brings together experts, researchers, and enthusiasts in the field of synthetic biology. This in-person conference will take place at the Laico Regency Hotel from Wed, Jul 17, 2024 to Friday, Jul 19, 2024.”

“Get ready to dive into the exciting world of synthetic biology and explore its potential applications in Africa. From cutting-edge research to innovative solutions, this conference offers a unique opportunity to learn, network, and collaborate with like-minded individuals.”

“Discover the latest advancements, trends, and challenges in synthetic biology through engaging keynote speeches, interactive workshops, and thought-provoking panel discussions. Immerse yourself in a vibrant atmosphere where ideas flow freely and new connections are made.”

“Whether you’re a seasoned professional or just starting your journey in synthetic biology, this conference provides a platform to expand your knowledge, exchange ideas, and contribute to the growth of the field in Africa.”

“Don’t miss out on this extraordinary event that promises to shape the future of synthetic biology and biosecurity in Africa. Mark your calendars and join us at the SBA.3 International Synthetic Biology and Biosecurity Conference in Africa!”

Learn more and register here.

Job Announcement: George Mason University, Research Faculty, Infectious Diseases

“The Institute for Biohealth Innovation harnesses the collective talent of more than 300 GMU faculty and staff and thousands of students across 34 academic departments. The IBI connects Mason researchers with potential collaborators, both within the university and externally, to take on some of biohealth’s biggest challenges.”

“The Biomedical Research Lab (BRL), is a core facility overseen by the Institute. The 52,000 square-foot regional biocontainment laboratory (RBL) was established in 2010 as one of 12 NIAID-funded RBLs to support infectious disease research and foster collaborations with other national and global laboratories. It operates as a central core facility to advance research and develop novel diagnostics, therapeutics, and vaccines against viral and bacterial infectious agents by a diverse population of internal and external investigators. The facility is capable of housing multiple species and has a variety of established animal models, with an emphasis on aerosolized exposures. The BRL is fully approved and licensed for work by the CDC and USDA and is accredited by AAALAC.”

“The research faculty will join a collaborative team that works on bacterial or viral pathogens relevant to human and animal disease. The research foci are within broad fields including but not limited to immunology and immunity in disease, host-pathogen interactions, cellular microbiology, biochemistry, animal imaging and pathology, aerobiology, and countermeasure development (diagnostics, vaccines, and therapeutics). The incumbent will work with a diverse team of internal and external investigators including faculty, postdoctoral fellows, undergraduate and graduate students, and industry professionals. The incumbent will be responsible for conducting research, providing training and mentorship, disseminating findings, and contributing to grant proposals to advance infectious disease research and countermeasure development.”

Learn more and apply here.

CEPI Calls for Experts to Join Its Scientific Advisory Committee

From CEPI: “CEPI’s call for new individuals to join its Scientific Advisory Committee, or SAC —an external expert group providing guidance and recommendations to CEPI on R&D programmes and broader outbreak response efforts—is now open through 9 April 2024.”

“CEPI is recruiting global health professionals with extensive experience across relevant scientific and product development disciplines to join its SAC, and is particularly interested in applicants from Latin America and Africa; female applicants are especially encouraged to apply.“

“Successful applicants’ scientific input, guidance and challenge will be critical in the continued implementation of the CEPI 2.0 strategy, which aims to accelerate the development of vaccines and other biological countermeasures to tackle emerging infectious diseases and enhance global preparedness for future threats.”

“New members’ terms will last three years, starting in June 2024, with the first face-to-face meeting taking place in Rio de Janeiro from 31 July to 1 August. Virtual participation will be made available for anyone unable to travel at this time.”

“Interested individuals can apply using our online form linked here.“